首页 > 最新文献

Mayo Clinic proceedings. Innovations, quality & outcomes最新文献

英文 中文
Emergency Department Visits Before Cancer Diagnosis Among Women at Mayo Clinic 梅奥诊所妇女癌症诊断前的急诊就诊情况
Pub Date : 2024-04-04 DOI: 10.1016/j.mayocpiqo.2024.03.002
Sally K. Stauder BS , Shalmali R. Borkar MBBS, MPH , Amy E. Glasgow MHA , Tage L. Runkle MA , Mark E. Sherman MD , Aaron C. Spaulding PhD , Michael M. Mohseni MD , Christopher C. DeStephano MD, MPH

Objective

To determine associations of incident cancer diagnoses in women with recent emergency department (ED) care.

Patients and Methods

A retrospective cohort study analyzing biological females aged 18 years and older, who were diagnosed with an incident primary cancer (12 cancer types studied) from January 1, 2015, to December 31, 2021, from electronic health records. The primary outcome was a cancer diagnosis within 6 months of a preceding ED visit. Secondary outcomes included patient factors associated with a preceding ED visit.

Results

Of 25,736 patients (median age of 62 years, range 18-101) diagnosed with an incident primary cancer, 1938 (7.5%) had an ED visit ≤6 months before a diagnosis. The ED-associated cancer cases were highest in lung cancer (n=514, 14.7%) followed by acute lymphoblastic leukemia (n=22, 13.3%). Patient factors increasing the likelihood of ED evaluation before diagnosis included 18-50 years of age (OR=1.32; 95% CI, 1.09-1.61), Elixhauser score (measure of comorbidities) >4 (OR=17.90; 95% CI, 14.21-22.76), use of Medicaid or other government insurance (OR=2.10; 95% CI, 1.63-2.69), residence within the institutional catchment areas (OR=3.18; 95% CI, 2.78-3.66), non-Hispanic Black race/ethnicity (OR=1.41; 95% CI, 1.04-1.88), and established primary care provider at Mayo Clinic (OR=1.45; 95% CI, 1.28-1.65). The ED visits were more likely in those who died within 6 months of diagnosis (n=327, 37.8%) than those who did not die (n=1611, 6.5%).

Conclusion

Patient characteristics identified in this study offer opportunities to provide cancer risk assessment and health navigation, particularly among individuals with comorbidities and limited health care access.

患者和方法该回顾性队列研究分析了从 2015 年 1 月 1 日至 2021 年 12 月 31 日期间电子健康记录中被诊断为原发性癌症(研究的 12 种癌症类型)的 18 岁及以上女性患者。主要结果是在前一次急诊就诊后 6 个月内确诊癌症。结果 在确诊为原发性癌症的 25736 名患者(中位年龄为 62 岁,年龄范围为 18-101 岁)中,有 1938 人(7.5%)在确诊前 6 个月曾在急诊室就诊。与急诊室相关的癌症病例以肺癌最多(514 例,14.7%),其次是急性淋巴细胞白血病(22 例,13.3%)。增加诊断前进行 ED 评估可能性的患者因素包括:18-50 岁(OR=1.32;95% CI,1.09-1.61)、Elixhauser 评分(衡量合并症)>4(OR=17.90;95% CI,14.21-22.76)、使用医疗补助或其他政府保险(OR=2.10;95% CI,1.63-2.69)、居住在机构覆盖区内(OR=3.18;95% CI,2.78-3.66)、非西班牙裔黑人种族/民族(OR=1.41;95% CI,1.04-1.88)、在梅奥诊所有固定的初级保健提供者(OR=1.45;95% CI,1.28-1.65)。与未死亡的患者(1611 人,6.5%)相比,诊断后 6 个月内死亡的患者(327 人,37.8%)更有可能去急诊室就诊。
{"title":"Emergency Department Visits Before Cancer Diagnosis Among Women at Mayo Clinic","authors":"Sally K. Stauder BS ,&nbsp;Shalmali R. Borkar MBBS, MPH ,&nbsp;Amy E. Glasgow MHA ,&nbsp;Tage L. Runkle MA ,&nbsp;Mark E. Sherman MD ,&nbsp;Aaron C. Spaulding PhD ,&nbsp;Michael M. Mohseni MD ,&nbsp;Christopher C. DeStephano MD, MPH","doi":"10.1016/j.mayocpiqo.2024.03.002","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2024.03.002","url":null,"abstract":"<div><h3>Objective</h3><p>To determine associations of incident cancer diagnoses in women with recent emergency department (ED) care.</p></div><div><h3>Patients and Methods</h3><p>A retrospective cohort study analyzing biological females aged 18 years and older, who were diagnosed with an incident primary cancer (12 cancer types studied) from January 1, 2015, to December 31, 2021, from electronic health records. The primary outcome was a cancer diagnosis within 6 months of a preceding ED visit. Secondary outcomes included patient factors associated with a preceding ED visit.</p></div><div><h3>Results</h3><p>Of 25,736 patients (median age of 62 years, range 18-101) diagnosed with an incident primary cancer, 1938 (7.5%) had an ED visit ≤6 months before a diagnosis. The ED-associated cancer cases were highest in lung cancer (n=514, 14.7%) followed by acute lymphoblastic leukemia (n=22, 13.3%). Patient factors increasing the likelihood of ED evaluation before diagnosis included 18-50 years of age (OR=1.32; 95% CI, 1.09-1.61), Elixhauser score (measure of comorbidities) &gt;4 (OR=17.90; 95% CI, 14.21-22.76), use of Medicaid or other government insurance (OR=2.10; 95% CI, 1.63-2.69), residence within the institutional catchment areas (OR=3.18; 95% CI, 2.78-3.66), non-Hispanic Black race/ethnicity (OR=1.41; 95% CI, 1.04-1.88), and established primary care provider at Mayo Clinic (OR=1.45; 95% CI, 1.28-1.65). The ED visits were more likely in those who died within 6 months of diagnosis (n=327, 37.8%) than those who did not die (n=1611, 6.5%).</p></div><div><h3>Conclusion</h3><p>Patient characteristics identified in this study offer opportunities to provide cancer risk assessment and health navigation, particularly among individuals with comorbidities and limited health care access.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 3","pages":"Pages 213-224"},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454824000122/pdfft?md5=d0c6ab1674cb5c9c76aef60175aad8e3&pid=1-s2.0-S2542454824000122-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140347059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Employee Dietary Initiative Improved Chronic Symptoms 员工饮食倡议改善慢性症状
Pub Date : 2024-04-04 DOI: 10.1016/j.mayocpiqo.2024.03.001
Nancy L. Sudak MD , Melissa L. Harry MSW, PhD

With the awareness that the Standard American Diet is a critical contributor to chronic diseases, this initiative aimed to assess the effects of a 28-day dietary challenge health care improvement project on health system employee energy level, sleep quality, gastrointestinal function, ability to concentrate, and aches/pains, including the impact of adherence level, during a period of restricted intake of gluten, dairy, and sugar offered annually from 2021 to 2023. A total of 754 employees completed the pre-challenge survey; analyses included 354 employees who completed both pre-challenge and post-challenge surveys in at least 1 year of this project. Wilcoxon signed rank tests compared presurvey and postsurvey responses to self-reported energy level, sleep quality, gastrointestinal function, ability to concentrate, and aches/pains. Analysis of variance with Tukey’s honestly significant difference tests compared self-reported adherence level with change scores, with η2 representing effect size. In each challenge year, the mean rank levels of energy, sleep quality, gastrointestinal function, concentration, and aches/pains improved significantly between pre-surveys and post-surveys (all P<.001). Although an association between significant positive change and diet adherence level was found for all items in at least 1 challenge year, those who mostly or completely adhered to the challenge diet restrictions reported significantly greater positive change in energy levels and gastrointestinal symptoms than those who did not or minimally adhered in all challenge years, with small to medium effect sizes. In conclusion, Essentia Health’s employee challenge appeared to improve self-reported outcomes in 5 symptom domains, with energy levels and gastrointestinal symptoms correlating most favorably to adherence to the challenge. These findings have health and cost implications, which could be confirmed by formal research in employee and other populations.

由于意识到 "美国标准饮食 "是慢性疾病的重要诱因,该项目旨在评估在 2021 年至 2023 年每年限制麸质食品、乳制品和糖的摄入期间,为期 28 天的饮食挑战保健改善项目对卫生系统员工的能量水平、睡眠质量、肠胃功能、集中注意力的能力以及疼痛/痛楚的影响,包括对坚持程度的影响。共有 754 名员工完成了挑战前调查;其中 354 名员工在本项目的至少 1 年中完成了挑战前和挑战后调查。Wilcoxon 符号秩检验比较了调查前和调查后对自我报告的能量水平、睡眠质量、肠胃功能、集中注意力的能力和疼痛/痛楚的反应。利用Tukey诚实显著差异检验进行的方差分析比较了自我报告的依从性水平和变化得分,η2代表效应大小。在每个挑战年中,能量、睡眠质量、肠胃功能、注意力和疼痛/痛楚的平均等级水平在调查前和调查后都有显著改善(均为 P<.001)。虽然在至少一个挑战年的所有项目中都发现了明显的积极变化与坚持饮食水平之间的关联,但在所有挑战年中,大部分或完全坚持挑战饮食限制的人在能量水平和胃肠道症状方面的积极变化明显大于未坚持或极少坚持的人,影响大小为小到中等。总之,Essentia Health 的员工挑战赛似乎改善了 5 个症状领域的自我报告结果,其中能量水平和胃肠道症状与坚持挑战赛的相关性最大。这些发现对健康和成本有影响,可以通过对员工和其他人群的正式研究加以证实。
{"title":"Employee Dietary Initiative Improved Chronic Symptoms","authors":"Nancy L. Sudak MD ,&nbsp;Melissa L. Harry MSW, PhD","doi":"10.1016/j.mayocpiqo.2024.03.001","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2024.03.001","url":null,"abstract":"<div><p>With the awareness that the Standard American Diet is a critical contributor to chronic diseases, this initiative aimed to assess the effects of a 28-day dietary challenge health care improvement project on health system employee energy level, sleep quality, gastrointestinal function, ability to concentrate, and aches/pains, including the impact of adherence level, during a period of restricted intake of gluten, dairy, and sugar offered annually from 2021 to 2023. A total of 754 employees completed the pre-challenge survey; analyses included 354 employees who completed both pre-challenge and post-challenge surveys in at least 1 year of this project. Wilcoxon signed rank tests compared presurvey and postsurvey responses to self-reported energy level, sleep quality, gastrointestinal function, ability to concentrate, and aches/pains. Analysis of variance with Tukey’s honestly significant difference tests compared self-reported adherence level with change scores, with η<sup>2</sup> representing effect size. In each challenge year, the mean rank levels of energy, sleep quality, gastrointestinal function, concentration, and aches/pains improved significantly between pre-surveys and post-surveys (all <em>P</em>&lt;.001). Although an association between significant positive change and diet adherence level was found for all items in at least 1 challenge year, those who mostly or completely adhered to the challenge diet restrictions reported significantly greater positive change in energy levels and gastrointestinal symptoms than those who did not or minimally adhered in all challenge years, with small to medium effect sizes. In conclusion, Essentia Health’s employee challenge appeared to improve self-reported outcomes in 5 symptom domains, with energy levels and gastrointestinal symptoms correlating most favorably to adherence to the challenge. These findings have health and cost implications, which could be confirmed by formal research in employee and other populations.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 3","pages":"Pages 201-212"},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454824000110/pdfft?md5=02ce49ae4a6be35062abc86901a38bd2&pid=1-s2.0-S2542454824000110-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140345245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnancy-Associated Cancer: A Systematic Review and Meta-Analysis 妊娠相关癌症:系统回顾和元分析
Pub Date : 2024-03-16 DOI: 10.1016/j.mayocpiqo.2024.02.002
Ben Walters MBChB , India Midwinter BSc, MBBS , Carolyn A. Chew-Graham MBChB, MD , Kelvin P. Jordan PhD , Garima Sharma MB , Lucy C. Chappell MB, BCh, PhD , Emma J. Crosbie MBChB, PhD , Purvi Parwani MBBS, MPH , Mamas A. Mamas BM BCh, DPhil , Pensée Wu MBChB, MD(Res)

This study aimed to systematically evaluate and quantify the risk of adverse maternal and neonatal outcomes in patients with pregnancy-associated cancer (PAC). This study was conducted from February 13, 2021, through July 24, 2023. A systematic search of MEDLINE, Embase, Web of Science Core Collection, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials was conducted to identify studies reporting outcomes for patients with PAC. The study was registered on PROSPERO. Two reviewers independently conducted screening, data extraction, and quality assessment. The associations were quantified using random-effects meta-analysis. The initial search produced 29,401 titles and abstracts, after which 147 unique full-text articles were screened, of which 22 articles with 59,190 pregnancies with PAC from 70,097,167 births were included in the meta-analysis. Women with PAC were at significantly increased risk of cesarean deliveries (risk ratio [RR], 1.58; 95% CI, 1.31-1.89), preterm birth (RR, 3.07; 95% CI, 2.37-3.98), venous thromboembolism (RR, 6.76; 95% CI, 5.08-8.99), and maternal death (RR, 41.58; 95% CI, 20.38-84.83). The only outcome with reduced risk was instrumental mode of delivery (RR, 0.67; 95% CI, 0.52-0.87). Pregnancy-associated cancer increases risk of adverse outcomes, including a 7-fold risk of venous thromboembolism and a 42-fold risk of maternal death. Further research is required to better understand the mechanisms leading to these adverse outcomes, especially for women who are not diagnosed until the postpartum period. Affected women should have counseling regarding their increased risk of adverse outcomes.

本研究旨在系统评估和量化妊娠相关癌症(PAC)患者不良孕产妇和新生儿结局的风险。本研究从 2021 年 2 月 13 日开始,至 2023 年 7 月 24 日结束。研究人员对 MEDLINE、Embase、Web of Science Core Collection、Cochrane 系统性综述数据库和 Cochrane 对照试验中央登记册进行了系统检索,以确定报告 PAC 患者预后的研究。研究已在 PROSPERO 上注册。两名审稿人独立进行筛选、数据提取和质量评估。采用随机效应荟萃分析法对相关性进行量化。最初的检索产生了 29,401 篇标题和摘要,随后筛选出 147 篇独特的全文文章,其中有 22 篇文章纳入了荟萃分析,这些文章涉及 70,097,167 例分娩中的 59,190 例 PAC 孕妇。患有 PAC 的妇女剖宫产(风险比 [RR],1.58;95% CI,1.31-1.89)、早产(RR,3.07;95% CI,2.37-3.98)、静脉血栓栓塞(RR,6.76;95% CI,5.08-8.99)和产妇死亡(RR,41.58;95% CI,20.38-84.83)的风险明显增加。唯一降低风险的结果是工具性分娩方式(RR,0.67;95% CI,0.52-0.87)。与妊娠相关的癌症会增加不良后果的风险,包括静脉血栓栓塞风险的 7 倍和孕产妇死亡风险的 42 倍。要更好地了解导致这些不良后果的机制,尤其是产后才确诊的妇女,还需要进一步的研究。受影响的妇女应就其不良后果风险的增加接受咨询。
{"title":"Pregnancy-Associated Cancer: A Systematic Review and Meta-Analysis","authors":"Ben Walters MBChB ,&nbsp;India Midwinter BSc, MBBS ,&nbsp;Carolyn A. Chew-Graham MBChB, MD ,&nbsp;Kelvin P. Jordan PhD ,&nbsp;Garima Sharma MB ,&nbsp;Lucy C. Chappell MB, BCh, PhD ,&nbsp;Emma J. Crosbie MBChB, PhD ,&nbsp;Purvi Parwani MBBS, MPH ,&nbsp;Mamas A. Mamas BM BCh, DPhil ,&nbsp;Pensée Wu MBChB, MD(Res)","doi":"10.1016/j.mayocpiqo.2024.02.002","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2024.02.002","url":null,"abstract":"<div><p>This study aimed to systematically evaluate and quantify the risk of adverse maternal and neonatal outcomes in patients with pregnancy-associated cancer (PAC). This study was conducted from February 13, 2021, through July 24, 2023. A systematic search of MEDLINE, Embase, Web of Science Core Collection, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials was conducted to identify studies reporting outcomes for patients with PAC. The study was registered on PROSPERO. Two reviewers independently conducted screening, data extraction, and quality assessment. The associations were quantified using random-effects meta-analysis. The initial search produced 29,401 titles and abstracts, after which 147 unique full-text articles were screened, of which 22 articles with 59,190 pregnancies with PAC from 70,097,167 births were included in the meta-analysis. Women with PAC were at significantly increased risk of cesarean deliveries (risk ratio [RR], 1.58; 95% CI, 1.31-1.89), preterm birth (RR, 3.07; 95% CI, 2.37-3.98), venous thromboembolism (RR, 6.76; 95% CI, 5.08-8.99), and maternal death (RR, 41.58; 95% CI, 20.38-84.83). The only outcome with reduced risk was instrumental mode of delivery (RR, 0.67; 95% CI, 0.52-0.87). Pregnancy-associated cancer increases risk of adverse outcomes, including a 7-fold risk of venous thromboembolism and a 42-fold risk of maternal death. Further research is required to better understand the mechanisms leading to these adverse outcomes, especially for women who are not diagnosed until the postpartum period. Affected women should have counseling regarding their increased risk of adverse outcomes.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 2","pages":"Pages 188-199"},"PeriodicalIF":0.0,"publicationDate":"2024-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454824000109/pdfft?md5=169a6d692819e0adfc18b447adb93d25&pid=1-s2.0-S2542454824000109-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140137710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluid and Salt Balance Are Things We Often Overlook: Could Our Understanding of Fluid Dynamics Change How We Tackle Heart failure? 体液和盐平衡是我们经常忽略的问题:我们对流体动力学的了解能否改变我们应对心力衰竭的方法?
Pub Date : 2024-03-06 DOI: 10.1016/j.mayocpiqo.2024.02.001
Shriya Sharma MBBS, Rohan Goswami MD
{"title":"Fluid and Salt Balance Are Things We Often Overlook: Could Our Understanding of Fluid Dynamics Change How We Tackle Heart failure?","authors":"Shriya Sharma MBBS,&nbsp;Rohan Goswami MD","doi":"10.1016/j.mayocpiqo.2024.02.001","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2024.02.001","url":null,"abstract":"","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 2","pages":"Pages 184-187"},"PeriodicalIF":0.0,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454824000092/pdfft?md5=35819c16ed5d8de713c78d95544ba8f7&pid=1-s2.0-S2542454824000092-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140052820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lifestyle Factors and Cancer: A Narrative Review 生活方式因素与癌症:叙述性综述
Pub Date : 2024-03-04 DOI: 10.1016/j.mayocpiqo.2024.01.004
Reya Sharman MD, MPH , Zoey Harris MD , Brenda Ernst MD , Dawn Mussallem DO , Ashley Larsen MS , Krisstina Gowin DO

Lifestyle factors and their impact on cancer prevention, prognosis, and survivorship are increasingly recognized in the medical literature. Lifestyle factors are primarily defined here as diet and physical activity. We conducted a narrative review of the primary published data, including randomized controlled trials and prospective studies, on the impact of primary lifestyle factors on oncogenesis and clinical outcomes in the preventative and survivorship setting. First, we discuss the oncogenic mechanisms behind primary lifestyle factors (diet, physical activity and, within these 2, obesity). Then, we discuss the impact of adherence to lifestyle guidelines and dietary patterns on cancer incidence based on primary data. Owing to the plethora of published literature, to summarize the data in a more efficient manner, we describe the role of physical activity on cancer incidence using summative systematic reviews. We end by synthesizing the primary data on lifestyle factors in the survivorship setting and conclude with potential future directions. In brief, the various large-scale studies investigating the role diet and physical activity have reported a beneficial effect on cancer prevention and survivorship. Although the impact of single lifestyle factors on cancer incidence risk reduction is generally supported, holistic approaches to address the potential synergistic impact of multiple lifestyle factors together in concert is limited. Future research to identify the potentially synergistic effects of lifestyle modifications on oncogenesis and clinical outcomes is needed, particularly in cancer subtypes beyond colorectal and breast cancers.

生活方式因素及其对癌症预防、预后和生存的影响在医学文献中得到越来越多的认可。这里的生活方式因素主要指饮食和体育锻炼。我们对已发表的主要数据进行了叙述性综述,包括随机对照试验和前瞻性研究,内容涉及主要生活方式因素对肿瘤发生的影响以及预防和生存期的临床结果。首先,我们讨论了主要生活方式因素(饮食、体育锻炼和肥胖)背后的致癌机制。然后,我们根据原始数据讨论遵守生活方式指南和饮食模式对癌症发病率的影响。由于已发表的文献众多,为了更有效地总结数据,我们采用总结性系统综述的方法来描述体育锻炼对癌症发病率的作用。最后,我们综合了有关幸存者生活方式因素的原始数据,并总结了未来的潜在发展方向。简而言之,对饮食和体育锻炼的作用进行调查的各种大规模研究报告称,饮食和体育锻炼对癌症预防和生存有好处。虽然单一生活方式因素对降低癌症发病风险的影响得到普遍支持,但解决多种生活方式因素协同作用的潜在协同影响的整体方法却很有限。未来需要开展研究,以确定生活方式的改变对肿瘤发生和临床结果的潜在协同作用,特别是在结直肠癌和乳腺癌以外的癌症亚型中。
{"title":"Lifestyle Factors and Cancer: A Narrative Review","authors":"Reya Sharman MD, MPH ,&nbsp;Zoey Harris MD ,&nbsp;Brenda Ernst MD ,&nbsp;Dawn Mussallem DO ,&nbsp;Ashley Larsen MS ,&nbsp;Krisstina Gowin DO","doi":"10.1016/j.mayocpiqo.2024.01.004","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2024.01.004","url":null,"abstract":"<div><p>Lifestyle factors and their impact on cancer prevention, prognosis, and survivorship are increasingly recognized in the medical literature. Lifestyle factors are primarily defined here as diet and physical activity. We conducted a narrative review of the primary published data, including randomized controlled trials and prospective studies, on the impact of primary lifestyle factors on oncogenesis and clinical outcomes in the preventative and survivorship setting. First, we discuss the oncogenic mechanisms behind primary lifestyle factors (diet, physical activity and, within these 2, obesity). Then, we discuss the impact of adherence to lifestyle guidelines and dietary patterns on cancer incidence based on primary data. Owing to the plethora of published literature, to summarize the data in a more efficient manner, we describe the role of physical activity on cancer incidence using summative systematic reviews. We end by synthesizing the primary data on lifestyle factors in the survivorship setting and conclude with potential future directions. In brief, the various large-scale studies investigating the role diet and physical activity have reported a beneficial effect on cancer prevention and survivorship. Although the impact of single lifestyle factors on cancer incidence risk reduction is generally supported, holistic approaches to address the potential synergistic impact of multiple lifestyle factors together in concert is limited. Future research to identify the potentially synergistic effects of lifestyle modifications on oncogenesis and clinical outcomes is needed, particularly in cancer subtypes beyond colorectal and breast cancers.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 2","pages":"Pages 166-183"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454824000080/pdfft?md5=d0ee4432474cab4ebc217bdcc193ca83&pid=1-s2.0-S2542454824000080-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promise of Lifestyle Medicine for Heart Disease, Diabetes Mellitus, and Cerebrovascular Diseases 生活方式医学治疗心脏病、糖尿病和脑血管疾病的前景
Pub Date : 2024-02-26 DOI: 10.1016/j.mayocpiqo.2023.11.005
Aleksandra Pikula MD , Mahima Gulati MD, MSc , Jonathan P. Bonnet MD, MPH , Sarah Ibrahim MN, PhD , Svetlana Chamoun MD, PhD , Andrew M. Freeman MD , Koushik Reddy MD

The burden of noncommunicable chronic diseases has relevant and negative consequences to persons, health care systems, and economies worldwide. Chronic diseases are the leading cause of disability and mortality and are responsible for 90% of health care expenditure. The most common chronic diseases are diabetes mellitus (DM), cardiovascular disease, and cerebrovascular disease (stroke and vascular cognitive impairment). Modifiable risk factors (MRFs) for these conditions include hypertension, hyperlipidemia, smoking, poor diet, and low-physical activity; with hypertension being the most prevalent MRF. Most MRFs can be successfully targeted through lifestyle medicine (LSM), which is a medical specialty that addresses the root causes of chronic diseases through its primary, secondary, and tertiary preventative approaches. Lifestyle medicine comprises 6 pillars (nutrition, physical activity, sleep health, stress reduction, social connections, and substance use) which through various behavioral approaches, focus on regular physical activity, healthy eating, good quality and quantity sleep, and meaningful social connections coupled with the reduction of stress and substance use. This paper will briefly review the evidence and promise of individual LSM pillars in addressing the underlying MRFs of DM, cardiovascular and cerebrovascular disease (specifically stroke and vascular cognitive impairment). Lifestyle medicine holds a great promise for comprehensive and much improved population health. However, the adoption of LSM at the societal scale requires a multifaceted approach and widespread integration would galvanize a paradigm shift to prevent, treat or reverse chronic diseases from the root causes and achieve health equity.

非传染性慢性病的负担对个人、医疗保健系统和全球经济造成了相关的负面影响。慢性病是导致残疾和死亡的主要原因,占医疗支出的 90%。最常见的慢性病是糖尿病(DM)、心血管疾病和脑血管疾病(中风和血管性认知障碍)。这些疾病的可改变风险因素(MRFs)包括高血压、高脂血症、吸烟、不良饮食和运动量少;其中高血压是最普遍的可改变风险因素。生活方式医学是一门通过一级、二级和三级预防方法解决慢性病根源的医学专业。生活方式医学包括六大支柱(营养、体育锻炼、睡眠健康、减压、社会联系和药物使用),通过各种行为方法,重点关注有规律的体育锻炼、健康饮食、优质和适量的睡眠、有意义的社会联系以及减少压力和药物使用。本文将简要回顾生活方式医学各个支柱在解决糖尿病、心脑血管疾病(特别是中风和血管性认知障碍)的潜在 MRF 方面的证据和前景。生活方式医学为全面和大幅改善人口健康带来了巨大希望。然而,在社会范围内采用生活方式医学需要采取多方面的方法,广泛的整合将促进模式的转变,从根源上预防、治疗或逆转慢性疾病,实现健康公平。
{"title":"Promise of Lifestyle Medicine for Heart Disease, Diabetes Mellitus, and Cerebrovascular Diseases","authors":"Aleksandra Pikula MD ,&nbsp;Mahima Gulati MD, MSc ,&nbsp;Jonathan P. Bonnet MD, MPH ,&nbsp;Sarah Ibrahim MN, PhD ,&nbsp;Svetlana Chamoun MD, PhD ,&nbsp;Andrew M. Freeman MD ,&nbsp;Koushik Reddy MD","doi":"10.1016/j.mayocpiqo.2023.11.005","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.11.005","url":null,"abstract":"<div><p>The burden of noncommunicable chronic diseases has relevant and negative consequences to persons, health care systems, and economies worldwide. Chronic diseases are the leading cause of disability and mortality and are responsible for 90% of health care expenditure. The most common chronic diseases are diabetes mellitus (DM), cardiovascular disease, and cerebrovascular disease (stroke and vascular cognitive impairment). Modifiable risk factors (MRFs) for these conditions include hypertension, hyperlipidemia, smoking, poor diet, and low-physical activity; with hypertension being the most prevalent MRF. Most MRFs can be successfully targeted through lifestyle medicine (LSM), which is a medical specialty that addresses the root causes of chronic diseases through its primary, secondary, and tertiary preventative approaches. Lifestyle medicine comprises 6 pillars (nutrition, physical activity, sleep health, stress reduction, social connections, and substance use) which through various behavioral approaches, focus on regular physical activity, healthy eating, good quality and quantity sleep, and meaningful social connections coupled with the reduction of stress and substance use. This paper will briefly review the evidence and promise of individual LSM pillars in addressing the underlying MRFs of DM, cardiovascular and cerebrovascular disease (specifically stroke and vascular cognitive impairment). Lifestyle medicine holds a great promise for comprehensive and much improved population health. However, the adoption of LSM at the societal scale requires a multifaceted approach and widespread integration would galvanize a paradigm shift to prevent, treat or reverse chronic diseases from the root causes and achieve health equity.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 2","pages":"Pages 151-165"},"PeriodicalIF":0.0,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454824000031/pdfft?md5=58d78cea9d5fe151634311a29262b548&pid=1-s2.0-S2542454824000031-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139985022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Series of Minimally Invasive Robotic-Assisted Resection of Cardiac Papillary Fibroelastoma: The Mayo Clinic Experience 机器人辅助微创切除心脏乳头状纤维母细胞瘤病例系列:梅奥诊所的经验
Pub Date : 2024-02-23 DOI: 10.1016/j.mayocpiqo.2024.01.001
Ali Ahmad MD , Edward A. El-Am MD , Piotr Mazur MD, PhD , Elias Akiki MD , Ahmed A. Sorour MD , Reto D. Kurmann MD , Kyle W. Klarich MD , Arman Arghami MD, MPH , Phillip G. Rowse MD , Richard C. Daly MD , Joseph A. Dearani MD

Papillary fibroelastomas (PFEs) are small, slowly growing benign cardiac tumors with clinically significant risk of embolization. Surgical excision is the definitive treatment of symptomatic PFE and is conventionally performed through a median sternotomy. In this study, we report a series of 12 patients, who underwent robotic-assisted PFE removal at the Mayo Clinic. PFE involved the mitral valve, left atrium, and tricuspid valve. No major complications occurred after the procedure, and most patients were discharged 4 days after the surgery. On follow-up, 1 patient demonstrated pericarditis.

乳头状纤维母细胞瘤(PFE)是一种生长缓慢的小型良性心脏肿瘤,临床上有明显的栓塞风险。手术切除是治疗无症状 PFE 的最终方法,传统上通过胸骨正中切口进行。在本研究中,我们报告了在梅奥诊所接受机器人辅助 PFE 切除术的 12 例患者。PFE 涉及二尖瓣、左心房和三尖瓣。术后未出现重大并发症,大多数患者术后4天即可出院。随访中,1 名患者出现心包炎。
{"title":"A Case Series of Minimally Invasive Robotic-Assisted Resection of Cardiac Papillary Fibroelastoma: The Mayo Clinic Experience","authors":"Ali Ahmad MD ,&nbsp;Edward A. El-Am MD ,&nbsp;Piotr Mazur MD, PhD ,&nbsp;Elias Akiki MD ,&nbsp;Ahmed A. Sorour MD ,&nbsp;Reto D. Kurmann MD ,&nbsp;Kyle W. Klarich MD ,&nbsp;Arman Arghami MD, MPH ,&nbsp;Phillip G. Rowse MD ,&nbsp;Richard C. Daly MD ,&nbsp;Joseph A. Dearani MD","doi":"10.1016/j.mayocpiqo.2024.01.001","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2024.01.001","url":null,"abstract":"<div><p>Papillary fibroelastomas (PFEs) are small, slowly growing benign cardiac tumors with clinically significant risk of embolization. Surgical excision is the definitive treatment of symptomatic PFE and is conventionally performed through a median sternotomy. In this study, we report a series of 12 patients, who underwent robotic-assisted PFE removal at the Mayo Clinic. PFE involved the mitral valve, left atrium, and tricuspid valve. No major complications occurred after the procedure, and most patients were discharged 4 days after the surgery. On follow-up, 1 patient demonstrated pericarditis.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 2","pages":"Pages 143-150"},"PeriodicalIF":0.0,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454824000018/pdfft?md5=fd8dda6c79e48af2268a31af1219db9b&pid=1-s2.0-S2542454824000018-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139942255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Exercise in Statin-Associated Muscle Symptoms Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 运动在他汀类药物相关肌肉症状结果中的作用:随机对照试验的系统回顾和元分析
Pub Date : 2024-02-17 DOI: 10.1016/j.mayocpiqo.2024.01.003
Laura A. Mangone MS , Oh Sung Kwon PhD , Blair T. Johnson PhD , Yin Wu PhD , Linda S. Pescatello PhD

Objective

To provide a synthesis of randomized controlled trials (RCTs) investigating statin-associated muscle symptoms (SAMS) in adults who underwent exercise training intervention.

Patients and Methods

We systematically searched 5 electronic databases for placebo-controlled RCTs through January 31, 2023. We included short-term and long-term exercise interventions that compared the efficacy and safety of exercise+statin vs exercise+placebo in healthy adults and reported SAMS preintervention and postintervention. Publication bias and methodological study quality assessments were performed.

Results

Five of 454 potentially qualifying RCTs met the inclusion criteria, all short-term exercise RCTs. Participants were predominantly physically inactive young to middle-aged (M=37.2 y) men (57%), 252 (49%) who were on statin therapy, and 271 (53%) on placebo. Of the 3 RCTs providing qualitative SAMS results, 19 (9%) out of 220 participants reported SAMS on exercise+statin and 10 (4%) out of 234 reported SAMS on exercise+placebo. There was no difference between exercise+statin vs exercise+placebo for maximal oxygen consumption (d=−0.18; 95% CI, −0.37 to 0.00; P=.06) or creatine kinase after short-term exercise (d=0.59; 95% CI, −0.06 to 1.25; P=.08). Participants in the exercise+statin group reduced low-density lipoprotein cholesterol vs exercise+placebo (d=−1.84; 95% CI, −2.28 to −1.39; P<.001). Most of the RCTs exhibited low levels of risk of bias (k=4, 80%) and achieved moderate methodological study quality (75.0%±5.2%).

Conclusion

Self-reported SAMs tended to be 5% greater after short-term exercise in statin users compared with placebo, although this difference did not achieve statistical significance. There remains an important need for placebo-controlled RCTs investigating the prevalence of statin-induced SAMS during exercise training.

患者和方法我们系统检索了 5 个电子数据库中截至 2023 年 1 月 31 日的安慰剂对照 RCT。我们纳入了短期和长期运动干预研究,这些研究比较了运动+他汀与运动+安慰剂对健康成人的疗效和安全性,并报告了干预前和干预后的 SAMS。结果在 454 项可能合格的 RCT 中,有 5 项符合纳入标准,均为短期运动 RCT。参与者主要是缺乏运动的中青年男性(M=37.2 岁)(57%),其中 252 人(49%)正在接受他汀类药物治疗,271 人(53%)正在接受安慰剂治疗。在提供SAMS定性结果的3项研究中,220名参与者中有19人(9%)报告了运动+他汀治疗的SAMS结果,234名参与者中有10人(4%)报告了运动+安慰剂治疗的SAMS结果。在最大耗氧量(d=-0.18;95% CI,-0.37 至 0.00;P=.06)或短期运动后肌酸激酶(d=0.59;95% CI,-0.06 至 1.25;P=.08)方面,运动+他汀组与运动+安慰剂组之间没有差异。与运动+安慰剂相比,运动+他汀组参与者的低密度脂蛋白胆固醇降低了(d=-1.84;95% CI,-2.28 至-1.39;P<.001)。结论他汀类药物使用者与安慰剂相比,短期运动后自我报告的SAMs往往高出5%,尽管这一差异未达到统计学意义。目前仍有必要进行安慰剂对照 RCT 研究,调查他汀类药物在运动训练期间引起的 SAMS 的发生率。
{"title":"The Role of Exercise in Statin-Associated Muscle Symptoms Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","authors":"Laura A. Mangone MS ,&nbsp;Oh Sung Kwon PhD ,&nbsp;Blair T. Johnson PhD ,&nbsp;Yin Wu PhD ,&nbsp;Linda S. Pescatello PhD","doi":"10.1016/j.mayocpiqo.2024.01.003","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2024.01.003","url":null,"abstract":"<div><h3>Objective</h3><p>To provide a synthesis of randomized controlled trials (RCTs) investigating statin-associated muscle symptoms (SAMS) in adults who underwent exercise training intervention.</p></div><div><h3>Patients and Methods</h3><p>We systematically searched 5 electronic databases for placebo-controlled RCTs through January 31, 2023. We included short-term and long-term exercise interventions that compared the efficacy and safety of exercise+statin vs exercise+placebo in healthy adults and reported SAMS preintervention and postintervention. Publication bias and methodological study quality assessments were performed.</p></div><div><h3>Results</h3><p>Five of 454 potentially qualifying RCTs met the inclusion criteria, all short-term exercise RCTs. Participants were predominantly physically inactive young to middle-aged (M=37.2 y) men (57%), 252 (49%) who were on statin therapy, and 271 (53%) on placebo. Of the 3 RCTs providing qualitative SAMS results, 19 (9%) out of 220 participants reported SAMS on exercise+statin and 10 (4%) out of 234 reported SAMS on exercise+placebo. There was no difference between exercise+statin vs exercise+placebo for maximal oxygen consumption (<em>d</em>=−0.18; 95% CI, −0.37 to 0.00; <em>P</em>=.06) or creatine kinase after short-term exercise (<em>d</em>=0.59; 95% CI, −0.06 to 1.25; <em>P</em>=.08). Participants in the exercise+statin group reduced low-density lipoprotein cholesterol vs exercise+placebo (<em>d</em>=−1.84; 95% CI, −2.28 to −1.39; <em>P</em>&lt;.001). Most of the RCTs exhibited low levels of risk of bias (<em>k</em>=4, 80%) and achieved moderate methodological study quality (75.0%±5.2%).</p></div><div><h3>Conclusion</h3><p>Self-reported SAMs tended to be 5% greater after short-term exercise in statin users compared with placebo, although this difference did not achieve statistical significance. There remains an important need for placebo-controlled RCTs investigating the prevalence of statin-induced SAMS during exercise training.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 2","pages":"Pages 131-142"},"PeriodicalIF":0.0,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454824000043/pdfft?md5=c5586b14864a68487b513e07604c35db&pid=1-s2.0-S2542454824000043-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139898575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral Health Clearance Outcomes for Cardiovascular Surgery 心血管手术的口腔健康清除结果
Pub Date : 2024-02-15 DOI: 10.1016/j.mayocpiqo.2024.01.002
Miao Xian Zhou DMD , Christopher F. Viozzi MD, DDS , Ondřej Heneberk , Sarah K. Lee DDS , Kyle W. Klarich MD , Thomas J. Salinas DDS

Objective

To determine the risk of morbidity and mortality in patients receiving dental extractions before planned cardiovascular surgery (CVS) and examine factors that may affect the chance of oral health clearance.

Patients and Methods

A retrospective medical record review was performed of patients who underwent dental screening before CVS from January 1, 2015, to December 31, 2021, at a major medical institution. A total of 496 patients met the inclusion criteria and were divided into 2 groups. Group 1 patients were cleared to advance to planned CVS (n=390). Group 2 patients were not cleared for surgery and subsequently underwent dental extractions before planned CVS (n=106).

Results

Six patients (5.7%) experienced postoperative complications after dental extraction that resulted in an emergency room visit. No deaths occurred after dental extraction before CVS. However, 4 patients died within 30 days of CVS, 3 from Group 1 (0.77%) and 1 from Group 2 (0.94%). Dental extraction before planned CVS showed a borderline significant association with death based on unadjusted (P=.06) and age-adjusted analysis (P=.05). Patients who reported seeing a dentist routinely had a significantly higher chance of oral health clearance (P <.001). No differences were noted between the 2 groups with regard to age, sex, or 30-day hospital readmission rate.

Conclusion

Patients who had dental extractions completed before planned CVS may be at an increased risk of mortality. Further studies are needed to examine this relationship. Emphasis should be on prioritization of routine dental visits before planned CVS.

目的确定在计划的心血管手术(CVS)前接受拔牙治疗的患者的发病率和死亡率风险,并研究可能影响口腔健康过关机会的因素。患者和方法对一家大型医疗机构 2015 年 1 月 1 日至 2021 年 12 月 31 日期间在心血管手术前接受牙科筛查的患者进行了回顾性病历审查。共有 496 名患者符合纳入标准,并被分为两组。第 1 组患者获准进行计划中的 CVS(人数=390)。结果6名患者(5.7%)在拔牙后出现术后并发症,导致急诊就诊。CVS 前拔牙后无死亡病例。但有 4 名患者在 CVS 术后 30 天内死亡,其中 3 人来自第一组(0.77%),1 人来自第二组(0.94%)。根据未调整分析(P=.06)和年龄调整分析(P=.05),在计划进行 CVS 之前拔牙与死亡有边缘显著性关联。报告定期看牙医的患者口腔健康过关的几率明显更高(P <.001)。结论在计划进行 CVS 之前完成拔牙的患者可能会增加死亡风险。需要进一步研究来探讨这种关系。应强调在计划进行 CVS 之前优先进行常规牙科检查。
{"title":"Oral Health Clearance Outcomes for Cardiovascular Surgery","authors":"Miao Xian Zhou DMD ,&nbsp;Christopher F. Viozzi MD, DDS ,&nbsp;Ondřej Heneberk ,&nbsp;Sarah K. Lee DDS ,&nbsp;Kyle W. Klarich MD ,&nbsp;Thomas J. Salinas DDS","doi":"10.1016/j.mayocpiqo.2024.01.002","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2024.01.002","url":null,"abstract":"<div><h3>Objective</h3><p>To determine the risk of morbidity and mortality in patients receiving dental extractions before planned cardiovascular surgery (CVS) and examine factors that may affect the chance of oral health clearance.</p></div><div><h3>Patients and Methods</h3><p>A retrospective medical record review was performed of patients who underwent dental screening before CVS from January 1, 2015, to December 31, 2021, at a major medical institution. A total of 496 patients met the inclusion criteria and were divided into 2 groups. Group 1 patients were cleared to advance to planned CVS (n=390). Group 2 patients were not cleared for surgery and subsequently underwent dental extractions before planned CVS (n=106).</p></div><div><h3>Results</h3><p>Six patients (5.7%) experienced postoperative complications after dental extraction that resulted in an emergency room visit. No deaths occurred after dental extraction before CVS. However, 4 patients died within 30 days of CVS, 3 from Group 1 (0.77%) and 1 from Group 2 (0.94%). Dental extraction before planned CVS showed a borderline significant association with death based on unadjusted (<em>P</em>=.06) and age-adjusted analysis (<em>P</em>=.05). Patients who reported seeing a dentist routinely had a significantly higher chance of oral health clearance (<em>P</em> &lt;.001). No differences were noted between the 2 groups with regard to age, sex, or 30-day hospital readmission rate.</p></div><div><h3>Conclusion</h3><p>Patients who had dental extractions completed before planned CVS may be at an increased risk of mortality. Further studies are needed to examine this relationship. Emphasis should be on prioritization of routine dental visits before planned CVS.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 2","pages":"Pages 121-130"},"PeriodicalIF":0.0,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S254245482400002X/pdfft?md5=0c853ec792958279280c8bf7548799db&pid=1-s2.0-S254245482400002X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139743832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Foundations of Lifestyle Medicine and its Evolution 生活方式医学的基础及其演变
Pub Date : 2024-01-20 DOI: 10.1016/j.mayocpiqo.2023.11.004
David Lippman MD , Mariah Stump MD, MPH , Erica Veazey MD , Sley Tanigawa Guimarães MD , Richard Rosenfeld MD, MPH, MBA , John H. Kelly MD, MPH , Dean Ornish MD , David L. Katz MD, MPH

Lifestyle Medicine (LM) is a rapidly growing discipline that focuses on the role of lifestyle factors in preventing, managing, and reversing chronic disease. At this point in the field’s evolution, there is strong evidence that the 6 pillars of LM—a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, avoidance of risky substances, and positive social connections—are central in the creation and maintenance of health. Previous publications, many of them randomized controlled studies and meta-analyses, have solidified the evidence base for the use of the 6 pillars within the field of LM. As data emerged, so did its governing body, the American College of Lifestyle Medicine (ACLM), and with it a rich history began to unfold. Several articles have been written on the early history of the ACLM and the growth of the field; however, this review article explores the history and foundation of LM, aiming to provide a comprehensive understanding of its relevance and impact on health care. It underscores landmark studies that have defined the field and provides a road map detailing national and global barriers and areas of potential future growth.

生活方式医学(LM)是一门快速发展的学科,它关注生活方式因素在预防、管理和逆转慢性疾病中的作用。在这一领域的发展过程中,有强有力的证据表明,生活方式医学的六大支柱--全食物、以植物为主的饮食模式、体育锻炼、恢复性睡眠、压力管理、避免危险物质以及积极的社会联系--是创造和维护健康的核心。以前发表的出版物,其中许多是随机对照研究和荟萃分析,为在健康管理领域使用六大支柱提供了坚实的证据基础。随着数据的出现,其管理机构--美国生活方式医学学会(ACLM)也随之成立,丰富的历史也随之展开。已有多篇文章介绍了美国生活方式医学会的早期历史和该领域的发展;然而,这篇综述文章探讨了生活方式医学的历史和基础,旨在全面了解其对医疗保健的相关性和影响。文章强调了定义该领域的标志性研究,并提供了一个路线图,详细说明了国家和全球障碍以及未来潜在的增长领域。
{"title":"Foundations of Lifestyle Medicine and its Evolution","authors":"David Lippman MD ,&nbsp;Mariah Stump MD, MPH ,&nbsp;Erica Veazey MD ,&nbsp;Sley Tanigawa Guimarães MD ,&nbsp;Richard Rosenfeld MD, MPH, MBA ,&nbsp;John H. Kelly MD, MPH ,&nbsp;Dean Ornish MD ,&nbsp;David L. Katz MD, MPH","doi":"10.1016/j.mayocpiqo.2023.11.004","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.11.004","url":null,"abstract":"<div><p>Lifestyle Medicine (LM) is a rapidly growing discipline that focuses on the role of lifestyle factors in preventing, managing, and reversing chronic disease. At this point in the field’s evolution, there is strong evidence that the 6 pillars of LM—a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, avoidance of risky substances, and positive social connections—are central in the creation and maintenance of health. Previous publications, many of them randomized controlled studies and meta-analyses, have solidified the evidence base for the use of the 6 pillars within the field of LM. As data emerged, so did its governing body, the American College of Lifestyle Medicine (ACLM), and with it a rich history began to unfold. Several articles have been written on the early history of the ACLM and the growth of the field; however, this review article explores the history and foundation of LM, aiming to provide a comprehensive understanding of its relevance and impact on health care. It underscores landmark studies that have defined the field and provides a road map detailing national and global barriers and areas of potential future growth.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 97-111"},"PeriodicalIF":0.0,"publicationDate":"2024-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000759/pdfft?md5=a1b46d38f00271da8f9afd56d05f08be&pid=1-s2.0-S2542454823000759-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139503379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mayo Clinic proceedings. Innovations, quality & outcomes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1